PB Fintech and Turtlemint have seen a combined market capitalization drop exceeding ₹35,700 crore over three sessions as investors digest IRDAI’s draft framework to cap product-level commissions, potentially reshaping commission-driven insurtech business models.
- PB Fintech lost ₹34,155.78 Cr, Turtlemint ₹1,548.96 Cr in three days
- IRDAI proposes new caps on commissions varying by product and channel
- Potential 10-12% earnings hit estimated from 10% commission cuts
What happened
Shares of PB Fintech and Turtlemint fell steeply over the past three trading sessions, collectively losing more than ₹35,700 crore in market value. PB Fintech’s stock price dropped over ₹30 per share early Monday, ending 1.17% down, while Turtlemint’s shares slipped 4.07%. This sharp decline follows the release of IRDAI’s consultation paper proposing a return to product-level commission caps after abandoning them three years prior.
The regulator’s draft framework suggests limiting commissions differently based on insurance product types, distribution channels, and sales efforts involved. This move aims to curb mis-selling and make insurance distribution costs more balanced for customers. However, given that commissions form a key revenue component and influence customer acquisition strategies for companies like PB Fintech and Turtlemint, the announcements triggered investor concerns about future profitability.
Why it matters
The commission caps proposed by IRDAI could majorly disrupt the revenue models of India’s insurtech companies, particularly those that rely heavily on commissions from policies sold through digital distribution channels. PB Fintech cofounder Yashish Dahiya has indicated the company may need to reconsider its approach, even exploring insurance manufacturing depending on future regulatory clarity.
Analysts like Jefferies highlight the risk such caps pose, estimating that a 10% reduction in new business commissions could decrease earnings by up to 12%. The proposal suggests significant cuts in commissions especially for health and motor insurance products, including zero commission on certain motor insurance third-party covers for distribution entities. This raises concerns about increased costs for customer acquisition and incentives, impacting overall business economics.
What to watch next
IRDAI has opened a public consultation period inviting stakeholder feedback until October 25 before finalizing the commission caps framework. The outcome of this consultation will be critical in shaping the regulatory landscape for insurance distribution in India and will influence strategic decisions by insurtech firms.
Investors will closely monitor any further official announcements and signals from companies like PB Fintech and Turtlemint regarding adjustments to their business models. Additionally, competitors’ responses and potential shifts toward alternate revenue streams or product lines will be important indicators of the sector’s evolution amid regulatory changes.